-
Start Preamble
By Notice dated October 2, 2008, and published in the Federal Register on October 8, 2008, (73 FR 58979), Clinical Supplies Management, Inc., 342 42nd. Street, South Fargo, North Dakota 58103, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Sufentanil (9740), a basic class of controlled substance listed in schedule II.
The company plans to import the listed controlled substance for clinical trials, research, and analytical purposes.
No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Clinical Supplies Management, Inc. to import the basic class of controlled substance is consistent with the public interest, and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971, at this time. DEA has investigated Clinical Supplies Management, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic class of controlled substance listed.
Start SignatureDated: January 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. E9-733 Filed 1-14-09; 8:45 am]
BILLING CODE 4410-09-P
Document Information
- Published:
- 01/15/2009
- Department:
- Drug Enforcement Administration
- Entry Type:
- Notice
- Document Number:
- E9-733
- Pages:
- 2619-2619 (1 pages)
- PDF File:
- e9-733.pdf